Brokerages Set Motus GI Holdings Inc (NASDAQ:MOTS) Target Price at $9.63
Motus GI Holdings Inc (NASDAQ:MOTS) has earned an average rating of “Buy” from the six brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $9.63.
MOTS has been the topic of a number of research analyst reports. Zacks Investment Research downgraded Motus GI from a “buy” rating to a “hold” rating in a research note on Thursday. ValuEngine upgraded Motus GI from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd. Finally, Piper Jaffray Companies cut their target price on Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th.
In other news, major shareholder Larry N. Feinberg acquired 1,031,666 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The shares were acquired at an average price of $3.00 per share, for a total transaction of $3,094,998.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman David P. Hochman acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The stock was purchased at an average price of $3.00 per share, for a total transaction of $30,000.00. The disclosure for this purchase can be found here. Insiders bought a total of 2,059,332 shares of company stock worth $6,179,896 in the last 90 days. Company insiders own 18.14% of the company’s stock.
Motus GI stock traded up $0.15 during midday trading on Tuesday, reaching $2.68. The stock had a trading volume of 36,900 shares, compared to its average volume of 86,832. Motus GI has a 12 month low of $2.34 and a 12 month high of $7.40. The company has a market capitalization of $72.78 million, a P/E ratio of -2.18 and a beta of 1.60. The company has a fifty day moving average price of $2.88 and a two-hundred day moving average price of $3.65. The company has a current ratio of 3.92, a quick ratio of 6.31 and a debt-to-equity ratio of 0.08.
Motus GI (NASDAQ:MOTS) last issued its earnings results on Friday, August 9th. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.03. On average, equities research analysts predict that Motus GI will post -1.05 earnings per share for the current fiscal year.
About Motus GI
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.